Some breast cancer patients can avoid certain surgeries, studies suggest
A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...
Pharmaceutical Technology6d
Ibrance by Pfizer for Papillary Renal Cell Carcinoma: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Pharmaceutical Technology6d
Ibrance by Pfizer for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Ibrance is under clinical development by Pfizer and currently in Phase III for Head And Neck Squamous Cell Carcinoma (HNSC).
Scientific Research Publishing2d
Understanding Breast Cancer: A Comprehensive Review of Epidemiology, Risk Factors, and Treatment Strategies ()
A Comprehensive Review of Epidemiology, Risk Factors, and Treatment Strategies. Advances in Breast Cancer Research, 14, 1-15. doi: 10.4236/abcr.2025.141001 . Noncommunicable diseases like various ...